Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways
IntroductionNon-alcoholic fatty liver disease (MASLD) is a common liver condition with a global prevalence of approximately 25%, often associated with overweight, obesity, and abnormalities in glucose and lipid metabolism. Its histological hallmark is hepatic steatosis. Non-alcoholic steatohepatitis...
Saved in:
| Main Authors: | Shi-Long Wang, Si Liang, Si-Yu Li, Jin-Wen Fu, Zi-Yi-Ru Wang, Dong-Qing Zhu, Nan Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1586678/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancement of oxaliplatin efficacy and amelioration of intestinal epithelial damage by Lactobacillus rhamnosus GG through modulation of gut microbiota
by: Zijie Zhang, et al.
Published: (2025-06-01) -
Gut microbiome in non-alcoholic fatty liver disease
by: Anastasios Mpountouridis, et al.
Published: (2025-01-01) -
Bovine colostrum-derived extracellular vesicles protect against non-alcoholic steatohepatitis by modulating gut microbiota and enhancing gut barrier function
by: Daye Mun, et al.
Published: (2025-01-01) -
A systematic review and meta-analysis of efruxifermin’s efficacy in improving liver fibrosis in patients with NASH/MASH
by: Shuzhai Li, et al.
Published: (2025-05-01) -
The Impact of Alcohol on the Gut Microbiota: A literature review
by: Jakub Sikora, et al.
Published: (2025-05-01)